Tata Consultancy Services announced a new pact with Eli Lilly. The Indian leader in IT consulting has 70,000 employees, 2,700 of whom are specialized in the life sciences. The company is publicly traded in India and recently reported about $1 billion in quarterly revenue. Both revenues and profits at the outsourcing firm are growing at a 40 percent pace. Novo-Nordisk and Novartis are Tata customers.

According to a news release, the new arrangement with Lilly is mostly related to clinical trial data services, and the news release quotes the Indiana executive who oversees such matters:

“For this multi-year engagement, Tata Consultancy Services has established a new facility, the ‘Lilly-TCS Medical Information Sciences Center’, at its Noida site near New Delhi, to house the staff working on Lilly projects. Through this new center, TCS will work with Lilly’s Medical Information Sciences disciplines to provide a wide range of services in clinical data management, statistical analysis and medical writing.

‘The goal of our relationship with TCS has several dimensions beyond reducing cost and risk, including gaining access to a global talent pool, increasing flexibility and scalability of our resources and maintaining a global workflow that is operational 24 hours a day,’ said Dr. Steve Ruberg, group director, global medical information sciences, Lilly.”